Carrageenan (CGN) is widely used in the food manufacturing industry as an additive that stabilizes and thickens food products. Standard animal safety studies in which CGN was administered in diet showed no adverse effects. However, several in vitro studies have reported that intestinal inflammation is caused by CGN and that this effect is mediated through Toll-Like-Receptor 4 (TLR4). The purpose of this study was to evaluate the ability of different types of CGN to bind and activate TLR4 signaling. To accomplish this a TLR4/MD-2/CD14/NFκB/SEAP reporter construct in a HEK293 cell line was used. The reporter molecule, secretable alkaline phosphatase (SEAP), was measured as an indicator of TLR4 activation. The test compounds were exposed to this system at concentrations of 0.1, 1, 10, 50, 100, 500, 1000, and 5000 ng/ mL for 24 h. Cytotoxicity was evaluated following the 24 h exposure period by LDH leakage and ATP. CGN binding to serum proteins was characterized by Toluidine Blue. The results show that CGN does not bind to TLR4 and is not cytotoxic to the HEK293 cells at the concentrations and experimental conditions tested and that CGN binds tightly to serum proteins.
Introduction
Carrageenan (CGN) is a high molecular weight (Mw = 200,000 to 800,000 Da) polysaccharide made up of repeating galactose units and 3,6 anhydrogalactose with varying numbers of sulfate groups connected by α-1,3 and β-1,4 glycosidic linkages. CGN is extracted from various species of red seaweed. It has been used in the food industry as a stabilizer and thickener for many decades with approvals from the Food and Drug Administration (FDA) and the Joint Expert Committee on Food Additives (JECFA). Early studies reported that CGN administered in drinking water or diet could cause intestinal inflammation and ulcers in animals (Benard et al., 2010; Fath et al., 1984; Moyana and Lalonde, 1991; Sharratt et al., 1971) . Later, it was determined that these studies and others were conducted with a different material: "degraded CGN," a sulfated polysaccharide with a similar structure to CGN, but with a lower Mw (10,000 to 20,000 Da) and different functional properties. Degraded CGN is now referred to as poligeenan (PGN) (USAN, 1988) . Because early work incorrectly and interchangeably used the term "carrageenan" to include both PGN and high molecular weight CGN, there has been considerable confusion in the scientific literature regarding the relationship between CGN and intestinal inflammation. This situation has been exacerbated by animal studies in which it was demonstrated that CGN injected into confined spaces in an animal's body, such as the rat hind paw, pleural space, or peritoneal cavity, can cause an acute inflammatory response. This exposure scenario and the local inflammation it induces, is not relevant to CGN used in foods. High molecular weight (Food-Grade) CGN is ingested at low dosages; is not absorbed across the intestinal epithelium, is wholly excreted in feces, does not enter the systemic circulation, and does not cause intestinal ulceration or inflammation. The safety of CGN is supported by a large number of animal oral safety studies in which no adverse effects were reported at high doses (up to 5% in diet) (reviewed by Weiner, 2014) .
In recent years several in vitro studies have been conducted using human cell lines. The scientific justification for these studies is based on the misperceptions (nomenclature and confined space injections) described above related to inflammation. These in vitro studies have concluded that CGN causes intestinal inflammation that is mediated through the innate immune system. The data from these studies were directly extrapolated to human safety, an extrapolation that raises concerns (McKim, 2014) .
One mechanism, proposed by the in vitro data, is that CGN binds to a membrane receptor known as Toll-Like-Receptor 4 (TLR4) and triggers a signaling cascade resulting in the expression of proinflammatory cytokines (Bhattacharyya et al., 2008a (Bhattacharyya et al., , 2008b . Activation of NF-κB and induction of IL-8 by CGN has been reported to occur via TLR4/ MyD88/IRAK/Bcl10 pathways in a human colonic NCM460 cell line (Bhattacharyya et al., 2008b; Borthakur et al., 2007) . In addition to the TLR4 mediated pathway, it has also been reported that reactive oxygen species generated intracellularly can enhance this proinflammatory response (Bhattacharyya et al., 2008c) . Because there are clear discrepancies between properly conducted animal safety studies in vivo, and the cell-based mechanistic studies in vitro, it is important to verify the in vitro findings (McKim, 2014) . If CGN is a ligand for human TLR4 and can activate proinflammatory pathways, then other human cell models with active TLR4 signaling pathways should also be stimulated by CGN.
Therefore, the aim of this study was to evaluate the ability of several forms (kappa, iota, lambda, food grade CGN, and a CGNmix) of well-characterized CGNs to bind to TLR4 and function as either an agonist or an antagonist. This was accomplished by using a well-defined HEK293 TLR4 reporter system linked to NF-κB promoter, which in turn guides the expression of the reporter molecule, secretable alkaline phosphatase (SEAP). Special care was taken to assure CGN identity and purity and to understand the potential impact of serum protein present in the cell culture medium on the availability of free CGN for interacting with cellular components. This latter consideration is important because CGN binds strongly to proteins in vivo and in vitro.
Materials and methods
All work reported in this study was done in full compliance with good laboratory practices (GLP).
Chemicals
Carrageenan (lambda, kappa, and iota) were from Sigma-Aldrich (St. Louis), food grade carrageenan, carrageenan-mix, clarified locust bean gum (CLBG), and sodium alginate (SA) were provided by FMC Corporation (Philadelphia, PA). Lipopolysaccharide (LPS) was from Sigma-Aldrich (St. Louis, MO). The HEK293-TLR4/MD-2/ CD14/NF-kB/SEAP reporter cell model and the SEAPorter™ Assay Kit were purchased from Imgenex (San Diego, CA). Dulbecco's Modified Eagle Medium (DMEM) and fetal bovine serum (FBS) were from Gibco/Invitrogen. The CytoTox-ONE™ kit for LDH was from Promega (Madison, WI). The ATPlite™ determination kit was from Perkin Elmer.
Characterization of carrageenan
The carrageenan samples were characterized from analytical data generated by FMC Quality Assurance, Rockland, ME in accordance with the identification, purity, and methods sections detailed in and published by FAO JECFA. {Prepared at the 79th JECFA (2014) Pure carrageenan content was determined by exhaustively washing the samples with a 60:40 v/v mix of 2-propanol and 1% sodium EDTA, followed by washing with 2-propanol, before oven drying and weighing the recovered pure anhydrous carrageenan. The 60% 2-propanol with EDTA washes out all inorganic salts and carbohydrate diluents such as sucrose and dextrose. The wash liquor was qualitatively tested for sugar standardizing agents, most commonly sucrose or dextrose, using Benedict's solution. One sample, lambda-carrageenan from Sigma Chemical, tested positive for dextrose, and this was calculated by difference using the other analytical data to be 36% of the total sample composition.
The analytical data were used to calculate the sample compositions: pure carrageenan, potassium chloride, calcium sulfate, moisture, and protein.
Carrageenan molecular weight profiling was carried out at Malvern Instruments, Herrenberg, Germany using gel permeation chromatography (GPC)/size exclusion chromatography (SEC)/refractive index (RI)/low angle light scattering (LALS)/ and right angle light scattering (RALS) (Marheineke, 2005) .
Cell culture and TLR4 reporter model
Human embryonic kidney (HEK293) cells, stably transfected with a TLR4/MD-2/CD14/NF-kB/SEAP reporter construct, were used in this study. This model system expresses full-length human toll-like receptor 4 (TLR4), human MD-2, human CD14, and secreted alkaline phosphatase (SEAP) under the control of an NFκB response element. Ligand binding to TLR4 and subsequent activation is measured by monitoring secretion of functional SEAP protein into the cell supernatant as directed by NFκB. The assay is a functional assay measuring SEAP activity outside of the cell. This reporter system has been used successfully by several other groups (Ahmed et al., 2012; Feng et al., 2010) to study chemical or drug related effects on TLR4-NF-κB signaling pathways.
HEK293 Cell culture was done as described previously (Rosenberg et al., 2010) and as directed by the manufacturer. Briefly, cells were seeded into a 96-well culture plate in Dulbecco's modified eagle medium (DMEM) containing 4.5 g/L glucose, 10% fetal bovine serum (FBS), 4 mM glutamine, 1 mM pyruvate, and recommended antibiotics at a density of 1 × 10 5 cells/well and allowed to acclimate for 16 h at 37°C in 5%CO2.
Preparation of reference compounds: preparation of lipopolysaccharide (LPS), clarified locust bean gum (CLBG), and sodium alginate (SA) control test materials
The positive control LPS and negative polysaccharide controls CLBG and SA were provided as λ-irradiated powders. Stock solutions of 1 mg/mL were prepared by adding 1 mL of sterile phosphate buffered saline (PBS) to 1 mg of test material in a sterile vial. In some instances the solutions were warmed (37°C) to help facilitate solubilization. Care was taken to maintain sterility and the stocks were stored at 4°C. Exposure concentrations of 0.1, 1, 10, 50, 100, 500, 1000, and 5000 ng/mL were prepared in either DMEM complete culture medium with 10% FBS or culture medium without FBS. After each test concentration was prepared, the media in each culture well was removed and replaced with 100 μL of the growth medium plus LPS, CLBG, or SA and allowed to incubate for 24 h. Table 1 shows the five types of CGN tested, their purity, and stock solution preparation. Stock solutions were prepared on the day of use in phosphate buffered saline (PBS). In some cases solubilization of test compounds required heating (max. 37°C)/ cooling and mixing to dissolve. The 1 mg/mL CGN solutions were corrected for purity and made up according to Table 1 .
Preparation of CGN
Exposure concentrations of 0.1, 1, 10, 50, 100, 500, 1000, and 5000 ng/mL were prepared in the DMEM complete culture medium with 10% FBS by adding an appropriate volume of the 1 mg/mL stock solution. After each test concentration was prepared, the media in each culture well was removed by gentle aspiration and replaced with 100 μL of the growth medium which contained either LPS, CLBG, SA, or CGN. Cells were exposed for 24 h.
Each test article and reference compounds were prepared at the same exposure concentrations with each concentration repeated in triplicate. This experimental set up was then repeated on a separate day and the data from both experiments were combined for analysis. An attempt was made to conduct these experiments in the absence of serum protein in the cell culture media; however, under these conditions LPS (positive control) had no effect on SEAP secretion indicating that serum factors are essential for functional TLR4 (data not shown).
Cell harvest
Following the 24 h exposure period, media were removed for analysis of SEAP activity and for cell viability by lactate dehydrogenase (LDH) activity. The cells were used for assessing viability via ATP levels. SEAP, LDH, and ATP analyses were done (1 mg/mL) 1 mg/mL 1 mg/mL 1 mg/mL 1 mg/mL 1 mg/mL immediately after harvest. The remaining media were stored at −80 o C for future analyses.
Determining TLR4 binding as a function of SEAP secretion (agonist activity)

The SEAPorter™ assay kit
The HEK cell line expressing TLR4 and SEAP reporter genes was validated by a ligand dose response assay (Rosenberg et al., 2010) and can be stimulated by LPS (Beutler, 2009; Lu et al., 2008) . LPS-mediated TLR4 activation results in increases in SEAP activity, as demonstrated by increase of SEAP into the cell supernatant (Rosenberg et al., 2010) . The SEAPorter™ assay kit was used to measure SEAP in the culture medium according to the manufacturer's instructions. Values from the SEAPorter™ assay were used to determine the EC50 of LPS, CLBG, SA, and CGN samples. The concentration response data obtained were used to determine an EC50, the concentration of LPS and test articles that are required for 50% activation of TLR4 as measured by SEAP activity (Rosenberg et al., 2010) .
Monitoring cytotoxicity 2.8.1. Membrane integrity (lactate dehydrogenase (LDH))
Cell viability was monitored over the concentration range of the study by measuring the membrane leakage marker LDH. The presence of LDH was measured in the culture medium using an LDH activity assay, CytoTox-ONE kit™. At the end of the exposure period, the medium covering the cells in each well was removed and placed into new 96-well plates with appropriate labeling. LDH activity was determined according to the manufacturer's instructions. The assay is a coupled enzymatic assay that relies on LDH to convert lactate to pyruvate and in the process generates NADH. In the presence of the enzyme diaphorase, resazurin is converted to the fluorescent product resorufin. Fluorescent signal is directly proportional to the amount of LDH present in the cell medium. Fluorescence is read at an excitation wave length of 560 nm and an emission wave length of 590 nm.
Measuring cellular ATP (Adenosine triphosphate)
ATP is present in all-living cells and declines rapidly when mitochondria are damaged or upon cell death. This assay provides an indicator of intracellular damage measured as mitochondrial function and energy status of the cell, both of which are indicators of cell health and viability. Cellular adenosine triphosphate (ATP) was determined by ATPlite according to the manufacturer's instructions. This assay is based on a reaction between ATP + D-luciferin + oxygen catalyzed by luciferase to yield oxyluciferin + AMP (adenosine monophosphate) + PPi (pyrophosphate) + CO2 (carbon dioxide) + light. The emitted light is proportional to the amount of ATP present in the cells. Rather than a "flash" type signal, which has a very short half-life, this assay utilizes a proprietary "glow" technology that extends the signal half-life to 5 h. In addition, a unique cell lysis reagent inhibits endogenous ATPases and therefore stabilizes cellular ATP by preventing its degradation to ADP.
At the end of the exposure period, the medium was removed from the cells and ATP cell lysis buffer added to each well. ATP was quantified by adding ATP substrate solution and then read using a luminescence-capable plate reader with luminescence expressed as relative luminescence units (RLU). Backgroundcorrected luminescence units were used to determine percent change relative to controls by dividing treated values by control values and multiplying by 100.
Data analysis and statistical methods
Basic statistical analysis was performed on the data, including means of well replicates, standard error of the mean, standard deviations, and coefficient of variation (%CV). Values within a dose group that varied from the mean by more than ±2 standard deviations were omitted from the final mean calculation. A one-way ANOVA statistical analysis on SEAP results was performed using GraphPad Prism version 5.01. Statistical significance (p < 0.05) is indicated with an asterisk.
Determining CGN protein binding
A key property of carrageenan (CGN) is its ability to bind strongly with positively charged protein sites through its ester sulfate groups. Most of the reported in vitro (cell-based) work to has been done in the presence of serum protein. It was, therefore, important to demonstrate the degree of CGN binding and the strength of binding. These experiments were done with the HEK293 culture media used in this study as well as with the media (M3:DC™) required for NCM460 cells, which also contains 10% FBS. Carrageenan was prepared at concentrations ranging from at least 1000 μg/mL down to 1 μg/mL or less in cell culture medium containing 10% FBS. The experiment was performed twice on two separate days with each concentration in triplicate. Experiments were prepared in culture medium/TCA matrix and in water. Measurement of free carrageenan was done using the Toluidine Blue (TB) assay. TB binds to free-CGN causing a color shift from blue to purple/pink, which can be measured spectrophotometrically at 630 nm (MacIntosh, 1941; Beattie et al, 1970).
Results
Interactions with TLR4
CGN has been purported to cause intestinal inflammation by binding to intestinal TLR4 and inducing pro-inflammatory mediators, such as NF-κB. In contrast, two polysaccharides, clarified locust bean gum (CLBG) and sodium alginate (SA), have not been implicated in gastrointestinal inflammation. To evaluate agonist as well as antagonist activity toward TLR4, several forms of CGN as well as positive (LPS) and negative (CLGB and SA) control compounds were tested for their ability to bind TLR4 and activate downstream signaling in the HEK-TLR4/MD-2/CD14/NF-κB/SEAP reporter system. An increase in secreted SEAP was an indication of TLR4 binding and activation of this NF-κB reporter system. The positive control, LPS, produced a concentration dependent increase in SEAP in cell media after 24 h (Fig. 1A) relative to vehicle controls. The negative controls CLBG and SA had no effect on SEAP release (Fig. 1B-E) . In comparison, multiple forms of CGN had no effect on SEAP . When CLBG and SA were co-administered with a concentration of LPS that results in a maximum increase in SEAP, there was no change in SEAP secretion (C and E). Cell viability was unaltered by exposure to CLBG, SA, or CGN as determined both by LDH leakage and intracellular ATP levels (Table 2) . Values represent the mean ± SEM of triplicate samples and two separate experiments. Statistical significance was assessed by ANOVA with p < 0.05.
secretion nor did CGN reduce the LPS response when coadministered ( Fig. 2A) . In contrast to LPS, the negative controls for intestinal inflammation (CLB and SA) showed no increase in SEAP (Fig. 1B and D) , indicating no interaction with TLR4. In the presence of a maximum inducing concentration of LPS (50 ng/mL), CLBG and SA also showed no antagonism of LPS binding to TLR4 (Fig. 1C and E) . Cytotoxicity was monitored by measuring intracellular ATP levels as well as leakage of the viability marker enzyme lactate dehydrogenase (LDH). LPS, CLBG, and SA had no measurable effect on cell health at the concentrations tested (Table 2) .
Even in the presence of LPS and CGN (antagonism experiments) there were no decreases in cell viability.
A unique and desired property of CGN is its ability to bind tightly to proteins. Most cell culture systems include fetal bovine serum (FBS) for optimal growth. It is therefore likely that under these conditions most of the CGN would be bound to protein and unavailable for cellular interaction. To test this, CGN was prepared in culture medium containing FBS and the amount of free CGN determined using the toluidine blue (TB) assay. Carrageenan was added to culture vessels at concentrations ranging from 0.1 to 1000 μg/mL. When CGN binds to toluidine blue there is a shift in the absorbance spectrum from blue to pink. Graphically, this appears as a reduction in absorbance and indicates free CGN. The human colonic epithelial cell line NCM460 has been used repeatedly to evaluate the effects of CGN on inflammation pathways. Therefore, in order to investigate CGN protein binding, the medium used with these cells was evaluated with and without protein (Fig. 3) . The graph on the left represents CGN in culture medium typically used with NCM460 cells but without protein. In the experiments without serum protein there was clear CGN binding to TB and a concentration dependant reduction in absorbance indicating the presence of free CGN (Fig. 3A) . The graph shown in Fig. 3B represents the results of the same experiment done in the presence of 10% serum. Free CGN was not detected until CGN exceeded 300 μg/mL with maximum amounts detected at 1000 μg/mL, which is 300-1000 times higher than the 1 μg/mL CGN used in the CGN experiments with the NCM460 cell line (Bhattacharyya et al., 2008c; Borthakur et al., 2007 Borthakur et al., , 2012 .
Discussion
In the present study, no evidence of CGN activation of TLR4 signaling pathways (agonist) or inhibition of TLR4 ligand binding (antagonist) were detected. These findings contradict findings reported in several previous in vitro studies (Bhattacharyya et al., 2008a; Borthakur et al., 2007 Borthakur et al., , 2008 , which reported that CGN can induce an inflammatory response by activation of TLR4 in a human NCM460 cell line. Although the TLR4-NF-κB-SEAP reporter system in the HEK293 cell line used in this study was different from the human colon epithelial (NCM460) cells used by others (Bhattacharyya et al., 2008a; Borthakur et al., 2007) , it is well suited for assessing potential CGN binding to TLR4. If CGN is truly an agonist for human TLR4 as reported, then it should bind to human TLR4 regardless of the test system. Important differences between this study and those reported previously (Bhattacharyya et al., 2008a; Borthakur et al., 2007) include the following: The CGN was thoroughly characterized with respect to identity and purity. We found that commercial CGN can be diluted with sugars (dextrose or sucrose) and, thus, the potential to inadvertently add contaminants is high (McKim, 2014) . Bacterial contamination in the laboratory and subsequent introduction of LPS to CGN can occur and the importance of testing for LPS contamination in CGN preparations has been reported (Tsuji et al., 2003) .
Another important factor not considered in previous studies is CGN protein binding. Most in vitro studies include fetal bovine serum in the culture medium. A desired property of CGN is that it binds strongly to proteins. Fig. 3 demonstrates that in the presence of FBS, free-CGN is not detected until the added CGN concentration exceeds 300-500 μg/mL, which is considerably higher than the low CGN (1 μg/mL) concentrations used in many of the in vitro studies reported (Bhattacharyya et al., 2008a; Borthakur et al., 2007 Borthakur et al., , 2008 . The immunostimulatory effects of LPS have been studied extensively. When LPS reaches excessive levels it can induce systemic inflammation and sepsis (Beutler and Rietschel, 2003) . The unique molecular structure of LPS is important to understand because it explains the mechanism by which it binds to TLR4 and induces a proinflammatory response. LPS is comprised of three parts: lipid A, a core oligosaccharide, and an O-side chain. However, it is the lipid component that is important for binding to TLR4 and which is attributed to its pathogen-associated-PAMP activity (Beutler and Rietschel, 2003; Biragyn et al., 2002) . In contrast to LPS, CGN does not have a lipid component.
Ligand binding to TLR4 requires several co-factor proteins (Fig. 4) . These include lipid-binding protein (LBP), which binds directly to the lipid component of LPS and enables LPS to recognize CD-14. CD-14 facilitates the transfer of LPS to the TLR4/MD-2 receptor complex. These proteins work together to control TLR4 recognition of LPS (Tobias et al., 1986; Wright et al., 1989 Wright et al., , 1990 . Direct binding of LPS to TLR4 does not occur (Beutler and Rietschel, 2003) . The complex control mechanisms governing substrate interaction with TLR4, as well as the series of intracellular signaling processes that result from TLR4 activation, are shown in the diagram in Fig. 4 . The result of these interactions is induction of NF-κB and an increase in proinflammatory cytokines. This complex process of TLR4 binding is relevant to CGN because it suggests that these protein cofactors would also need to bind CGN which seems improbable given its chemical structure.
A B
In conclusion the work reported here has shown that CGN does not act as an agonist or antagonist for TLR4 in a HEK293 reporter system. These in vitro findings are in good agreement with dietary studies done in animals with food-grade CGN, which have shown no intestinal inflammation. This work also underscores the need for interlaboratory corroboration of data that are used to determine human risk.
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